The oldest person to have gastric sleeve surgery is a question increasingly asked as bariatric procedures become more widely considered across all age groups. Sleeve gastrectomy — which removes approximately 75–80% of the stomach — is one of the most commonly performed weight loss operations in the UK. While no single universally recognised record exists, published case reports document patients in their 70s and 80s undergoing the procedure. This article examines the evidence on age and gastric sleeve surgery, how older adults are assessed on the NHS, relevant NICE guidance, and what recovery and long-term outcomes look like in later life.

Age and Gastric Sleeve Surgery: What the Evidence Shows

Age alone should not be an automatic barrier to sleeve gastrectomy; carefully selected patients in their 70s and 80s have undergone the procedure, with outcomes closely tied to physiological reserve rather than chronological age.

Gastric sleeve surgery, formally known as sleeve gastrectomy, involves the surgical removal of approximately 75–80% of the stomach, leaving a narrow, sleeve-shaped pouch. This restricts food intake and reduces levels of ghrelin, the hunger-regulating hormone, making it one of the most commonly performed bariatric procedures in the UK and worldwide.

While bariatric surgery has traditionally been associated with younger and middle-aged adults, there is a growing body of evidence examining its safety and efficacy in older populations. Published case reports and retrospective studies have documented patients in their 70s and, in some instances, their 80s undergoing sleeve gastrectomy. However, perioperative risk is generally higher in older cohorts, and patient selection is correspondingly more stringent. There is no single universally recognised record for the 'oldest person to have gastric sleeve' surgery; individual cases are reported across different institutions and countries. In the UK, the National Bariatric Surgery Registry (NBSR) collects outcomes data by age group and procedure type, providing the most robust domestic evidence base for understanding how older adults fare following bariatric surgery.

What the evidence does consistently show is that age alone should not be an automatic barrier to bariatric surgery. Research published in journals such as Obesity Surgery suggests that carefully selected older adults can achieve meaningful weight loss and improvements in obesity-related comorbidities, including type 2 diabetes, hypertension, and obstructive sleep apnoea. However, outcomes are closely tied to the thoroughness of pre-operative assessment and the overall physiological reserve of the individual patient, rather than chronological age in isolation.

How Older Adults Are Assessed for Bariatric Surgery on the NHS

Older adults follow the NHS Tier 3 to Tier 4 bariatric pathway, with additional assessments including frailty scoring, cardiopulmonary fitness testing, OSA screening, and cognitive evaluation before surgery is approved.

In the NHS, access to bariatric surgery — including sleeve gastrectomy — follows a structured, tiered pathway. Patients are typically required to engage with Tier 3 specialist weight management services (community or hospital-based multidisciplinary programmes) before progressing to Tier 4 bariatric surgery services, where surgical assessment and intervention take place. This progression is particularly important for older adults, where the balance of risk and benefit requires careful individual evaluation.

The multidisciplinary team at a Tier 4 centre may include a bariatric surgeon, dietitian, psychologist, anaesthetist, and specialist physician. For older patients, the assessment places particular emphasis on:

• Functional status and frailty scoring — tools such as the Clinical Frailty Scale (CFS) help clinicians determine whether a patient has sufficient physiological reserve to tolerate major surgery and recover effectively.

• Cardiovascular and respiratory fitness — older adults are more likely to have pre-existing cardiac or pulmonary conditions that increase anaesthetic and surgical risk. Cardiopulmonary exercise testing (CPET) may be used where indicated, and ASA (American Society of Anesthesiologists) grade is routinely assigned.

• Obstructive sleep apnoea (OSA) screening — OSA is common in people with obesity and carries additional anaesthetic risk; pre-operative identification and treatment are important.

• Smoking cessation — patients who smoke are strongly advised to stop before surgery to reduce respiratory and wound-healing complications.

• Nutritional status — age-related changes in metabolism and physiology mean that post-operative nutritional deficiencies (particularly in vitamin B12, iron, calcium, and vitamin D) may be more pronounced and require careful monitoring.

• Cognitive function and psychological readiness — the ability to adhere to significant long-term dietary and lifestyle changes is assessed carefully.

The NHS does not impose a strict upper age limit for bariatric surgery, but each case is considered on its individual merits. The multidisciplinary team must be satisfied that the anticipated benefits outweigh the procedural risks for that specific individual, in line with NHS England's service specification for Tier 4 bariatric surgery.

Risks and Benefits of Gastric Sleeve Surgery in Later Life

Sleeve gastrectomy can improve type 2 diabetes, hypertension, and mobility in older adults, but carries elevated risks of venous thromboembolism, GORD, sarcopenia, and nutritional deficiencies requiring lifelong monitoring.

Like all major surgical procedures, sleeve gastrectomy carries inherent risks, and these may be elevated in older adults due to age-related physiological changes. Understanding both the potential benefits and the risks is essential for informed decision-making.

Potential benefits for older adults include:

• Significant and sustained weight loss, reducing mechanical load on joints and improving mobility

• Improvement or remission of type 2 diabetes, often within weeks of surgery

• Reduction in cardiovascular risk factors, including hypertension and dyslipidaemia

• Improved quality of life and functional independence

• Reduced reliance on multiple medications (polypharmacy), which is particularly relevant in older patients

Risks that are of particular concern in older patients include:

• Surgical and anaesthetic complications — including venous thromboembolism, wound infection, and respiratory complications, all of which carry higher baseline risk with advancing age

• Gastro-oesophageal reflux disease (GORD) — sleeve gastrectomy can cause new or worsened GORD in some patients. This may require long-term proton pump inhibitor (PPI) therapy or, in a minority of cases, conversion to a different bariatric procedure. Patients with significant pre-existing GORD should discuss this risk carefully with their surgical team

• Gallstone formation — rapid weight loss increases the risk of gallstones. Ursodeoxycholic acid prophylaxis may be considered depending on local clinical policy

• Nutritional deficiencies — sleeve gastrectomy is primarily a restrictive procedure with hormonal effects; it does not cause significant malabsorption in the way that gastric bypass does. However, reduced food intake and altered physiology can lead to deficiencies in vitamin B12, iron, calcium, vitamin D, and other micronutrients. Older adults are already at greater risk of osteoporosis and sarcopenia, making lifelong supplementation and monitoring particularly important (see below)

• Staple line leak — a rare but serious complication requiring prompt surgical intervention

• Slower recovery — healing and rehabilitation may take longer, and hospital stays may be extended

It is worth noting that obesity itself carries significant health risks in older adults, and in some cases the risks of untreated severe obesity may outweigh the surgical risks. This is why individualised assessment, rather than blanket age-based exclusion, is considered best practice.

Lifelong supplementation and monitoring: In line with guidance from the British Obesity and Metabolic Surgery Society (BOMSS), patients are advised to take lifelong vitamin and mineral supplements following sleeve gastrectomy. Micronutrient blood tests are typically recommended at 3, 6, and 12 months post-operatively, and then annually thereafter. Older patients should ensure these reviews are maintained and flagged to their GP.

NICE Guidelines on Weight Loss Surgery for Older Patients

NICE CG189 sets no upper age limit for bariatric surgery; eligibility requires a BMI of 40 kg/m² or above (or 35–39.9 kg/m² with a significant comorbidity), completion of Tier 3, and fitness for anaesthesia.

The National Institute for Health and Care Excellence (NICE) provides guidance on bariatric surgery primarily through clinical guideline CG189 (Obesity: identification, assessment and management) and the associated quality standard QS127. These guidelines outline the criteria under which weight loss surgery should be considered and do not specify a maximum age for eligibility.

According to NICE CG189, bariatric surgery should be considered for adults who meet the following criteria:

• A BMI of 40 kg/m² or above, or a BMI of 35–39.9 kg/m² with a significant obesity-related comorbidity such as type 2 diabetes or hypertension

• Completion of a structured weight management programme (Tier 3)

• Fitness for anaesthesia and surgery

• Commitment to long-term follow-up

NICE also includes a special provision for people with recent-onset type 2 diabetes: surgery may be considered at a BMI of 30–34.9 kg/m² if type 2 diabetes has not been adequately controlled by other means, and expedited access may be appropriate at higher BMI thresholds. Additionally, NICE advises that lower BMI thresholds may be clinically appropriate for people from some minority ethnic groups, who are at increased risk of obesity-related conditions at lower body weights.

NICE guidance emphasises that decisions should be made on an individual basis, taking into account the patient's overall health, comorbidities, and personal circumstances. For older adults, age is considered as one factor among many, rather than a definitive contraindication. Post-operative follow-up should include regular monitoring of nutritional status and psychological wellbeing — areas of particular relevance to elderly patients. NICE and BOMSS recommend a minimum of two years of follow-up with the surgical team, followed by lifelong annual review in primary care.

Clinicians are encouraged to use shared decision-making, ensuring that patients fully understand the lifelong dietary changes required after sleeve gastrectomy, including the need for permanent vitamin and mineral supplementation.

Recovery and Long-Term Outcomes for Elderly Patients

Well-selected older adults can achieve meaningful weight loss and improved quality of life after sleeve gastrectomy, though recovery may take longer and protein intake with resistance exercise is essential to prevent sarcopenia.

Recovery from sleeve gastrectomy in older adults follows the same general trajectory as in younger patients, but may require additional support and a longer timeline. Most patients are discharged from hospital within two to three days following an uncomplicated laparoscopic procedure, though older adults may require a slightly extended stay depending on their baseline health status and post-operative progress.

In the immediate post-operative period, patients follow a staged dietary progression — moving from fluids to purées and then to soft foods over several weeks. Older adults may find this transition more challenging, particularly if they have pre-existing swallowing difficulties or reduced appetite. Close dietetic support during this phase is essential.

Long-term outcomes in older bariatric patients are generally positive when patients are well-selected, though it is important to note that outcomes in older adults may differ somewhat from those in younger cohorts:

• Meaningful weight loss — typically in the range of 50–60% of excess body weight over five years — is achievable in well-selected older patients, though some studies suggest slightly lower excess weight loss compared with younger adults

• Improvements in mobility and physical function can significantly enhance independence and quality of life

• Rates of type 2 diabetes remission are meaningful but may be somewhat lower in older patients, particularly those with longer diabetes duration prior to surgery; duration of diabetes is a key predictor of remission

Data from the National Bariatric Surgery Registry (NBSR) provide the most relevant UK-specific evidence on outcomes by age group and procedure, and clinicians and patients are encouraged to refer to the most recent NBSR report when discussing realistic expectations.

Sarcopenia — the age-related loss of muscle mass — is an important concern. Without adequate protein intake and physical activity, weight loss following sleeve gastrectomy can include a disproportionate loss of lean muscle tissue. In line with BOMSS guidance, older patients are encouraged to prioritise high-protein foods (aiming for at least 60–80 g of protein per day, as advised by their dietitian) and to engage in resistance-based exercise as part of their recovery plan, under appropriate supervision.

Talking to Your GP About Gastric Sleeve Surgery as an Older Adult

Your GP is the first point of contact for bariatric surgery referral; they can assess eligibility, initiate the Tier 3 pathway, and discuss non-surgical alternatives such as semaglutide (Wegovy) where appropriate.

If you are an older adult considering gastric sleeve surgery, your GP is the most appropriate first point of contact. A frank and open conversation about your weight, health history, and treatment goals will help your GP determine whether a referral to a Tier 3 specialist weight management service — the usual first step on the NHS pathway — is appropriate in your case.

Before your appointment, it may be helpful to consider and note down:

• Your current BMI and any obesity-related health conditions (e.g., type 2 diabetes, joint pain, sleep apnoea)

• Previous attempts at weight loss, including dietary programmes, medication, or other interventions

• Any concerns you have about surgery, anaesthesia, or recovery

• Your support network at home, as post-operative recovery requires practical assistance

When to seek prompt advice: If you are experiencing significant health deterioration related to your weight — such as worsening diabetes control, increasing breathlessness, or reduced mobility — you should not delay speaking to your GP, as timely intervention may be clinically important.

Your GP may also discuss non-surgical alternatives, including pharmacological options such as GLP-1 receptor agonists. Semaglutide (Wegovy) is approved by NICE under Technology Appraisal TA875 for use in adults with a BMI of 35 kg/m² or above (or 30 kg/m² or above in certain circumstances) alongside at least one weight-related comorbidity. Importantly, Wegovy is available only through specialist weight management services on the NHS, is intended for use alongside dietary and lifestyle support, and is currently approved for a maximum of two years. Common side effects include nausea, vomiting, and other gastrointestinal symptoms. If you are prescribed any medicine for weight management and experience unexpected side effects, you can report these to the MHRA Yellow Card scheme at yellowcard.mhra.gov.uk. For older adults with frailty or multiple long-term conditions, the suitability of GLP-1 receptor agonists should be discussed carefully with a clinician.

Experiencing these side effects? Our pharmacists can help you navigate them →

Ultimately, the decision to pursue gastric sleeve surgery at any age — including in later life — should be made collaboratively between you, your GP, and a specialist multidisciplinary team. Age is a consideration, but it need not be a barrier to accessing safe, effective, and life-improving treatment.

Frequently Asked Questions